Showing 981 - 1,000 results of 99,520 for search '(( 5 non decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.62s Refine Results
  1. 981

    Reduction of SIRT1 during DNA damage decreases the number of silent clones that have methylation. by Heather M. O'Hagan (271283)

    Published 2008
    “…One representative bisulfite sequenced clone is presented for each HSVTK silent clone. (B) A dot plot of the mean number of CpGs methylated per HSVTK silenced clone from either un-siRNA treated cells (untreated) (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000155#pgen-1000155-g005" target="_blank">Figure 5D & E</a>), non-target siRNA treated cells (NT), or SIRT1 siRNA treated cells (SIRT1). …”
  2. 982
  3. 983
  4. 984

    Photoinactivation of PSD-95-4c decreases GluR2 staining with no changes in NR1 or TfR staining. by Guillermo A. Yudowski (102587)

    Published 2013
    “…Only GluR2 in the FlAsH group showed a significant decrease (16% ±5 <i>n</i> = 7). (C) PSD-95-4c distribution was not changes after FALI. …”
  5. 985
  6. 986

    Influence of the Lactotripeptides Isoleucine–Proline–Proline and Valine–Proline–Proline on Systolic Blood Pressure in Japanese Subjects: A Systematic Review and Meta-Analysis of Ra... by Aurelie Chanson-Rolle (758940)

    Published 2015
    “…The analysis showed that consumption of IPP/VPP induced a significant reduction in SBP as compared with placebo in Japanese subjects, with an estimated effect of -5.63 mm Hg (95% CI, -6.87 to -4.39, P<0.0001) and no evidence of publication bias. …”
  7. 987
  8. 988
  9. 989
  10. 990
  11. 991

    Image_2_MicroRNA-20a-5p Ameliorates Non-alcoholic Fatty Liver Disease via Inhibiting the Expression of CD36.tif by Xin Wang (91924)

    Published 2020
    “…<p>Fatty acid translocase CD36 (CD36) plays an important role in the initiation and pathogenesis of chronic liver disease and non-alcoholic fatty liver disease (NAFLD). The purpose of this study is to investigate the regulation of microRNA-20a-5p (miR-20a-5p) on CD36 in the pathogenesis of NAFLD. …”
  12. 992

    Image_1_MicroRNA-20a-5p Ameliorates Non-alcoholic Fatty Liver Disease via Inhibiting the Expression of CD36.TIF by Xin Wang (91924)

    Published 2020
    “…<p>Fatty acid translocase CD36 (CD36) plays an important role in the initiation and pathogenesis of chronic liver disease and non-alcoholic fatty liver disease (NAFLD). The purpose of this study is to investigate the regulation of microRNA-20a-5p (miR-20a-5p) on CD36 in the pathogenesis of NAFLD. …”
  13. 993

    Image_3_MicroRNA-20a-5p Ameliorates Non-alcoholic Fatty Liver Disease via Inhibiting the Expression of CD36.TIF by Xin Wang (91924)

    Published 2020
    “…<p>Fatty acid translocase CD36 (CD36) plays an important role in the initiation and pathogenesis of chronic liver disease and non-alcoholic fatty liver disease (NAFLD). The purpose of this study is to investigate the regulation of microRNA-20a-5p (miR-20a-5p) on CD36 in the pathogenesis of NAFLD. …”
  14. 994

    Positive modulation of mGluR5 decreases spine density in the nucleus accumbens but not in the dorsal striatum. by Kellie S. Gross (3115299)

    Published 2016
    “…<p>(A) Twenty-four hours after systemic administration, CDPPB (5–10 mg/kg, <i>n</i> = 18 animals) decreased dendritic spine density and frequency of small head diameter spines (0.2 μm bin) compared to vehicle control (<i>n</i> = 8) in the nucleus accumbens core. …”
  15. 995
  16. 996

    The ratio between the bias in the naïve SI and shuffle SI decreases with tuning specificity, but not with sample size. by Liron Sheintuch (12078310)

    Published 2022
    “…Data pooled from N = 9 simulations, each corresponding to behavioral data from a different mouse. (B) The bias ratio (mean ± SEM) decreases as a function of the true SI for a sample size of 1 minute (blue), 5 minutes (cyan) and 20 minutes (green). …”
  17. 997
  18. 998
  19. 999
  20. 1000